Fluid Handling Dynamics and Durability of Silver-Containing Gelling Fiber Dressings Tested in a Robotic Wound System.
Aleksei Orlov, Adi Lustig, Angela Grigatti and 1 others
PMID 35293376WHAT IT FOUND
In simulated cavity wounds, the PVA silver gelling fiber dressing moved more fluid into the secondary dressing and stayed stronger when pulled.
The CMC silver dressing depended on seam direction and could tear. These are lab findings, not patient outcomes.
Key findings
01In the robotic wound system, the ExAg-PVA primary dressing paired with the foam secondary dressing moved more fluid into the secondary dressing than the Ag-CMC pair; after 15 hours, the secondary dressing retained 54.2% of fluid with ExAg-PVA and 36.7% with Ag-CMC (P < .05).
02Microscopy showed the Ag-CMC fibers had a strong directional preference: its fiber orientation index was 60.8 ± 48.8, while ExAg-PVA was 15.6 ± 11.8, about 3.9-fold lower (P < .05).
03After simulated use, pulling the Ag-CMC dressing out of alignment with its reinforcing seams reduced its strength by more than 8-fold (P < .05); at 10 and 15 hours its out-of-alignment strength was approximately four and six times lower than ExAg-PVA (P < .05).
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
No patients were tested. The wounds were silicone and paraffin phantoms, so this cannot show healing, infection, pain, or skin damage in people. Only offloaded wounds were simulated. Wounds under body weight or medical-device pressure, such as sacral pressure injuries or venous leg ulcers, were not tested. The exudate substitute was made from xanthan gum, not real wound fluid from specific patients or infected wounds. Only two primary dressings and one secondary dressing were tested, so the results do not cover all silver gelling fiber products or dressing pairs. The authors developed the robotic system and testing protocol, and the paper says the findings need further validation and reliability studies before informing practice.
The easy way to misread this
Do not read this as evidence that ExAg-PVA heals wounds better or is safer in patients. It was tested only in simulated wounds, and the authors state that laboratory findings need validation in randomized controlled trials.